Cheryl R Blanchard Anika Therapeutics, Inc. (ANIK) insider trading activity
Cheryl R Blanchard is President, CEO, Director of Anika Therapeutics, Inc.. Currently has a direct ownership of 151,694 shares of ANIK, which is worth approximately $2.62 Million. The most recent transaction as insider was on Mar 11, 2024, when has been sold 27,980 shares (Common Stock) at a price of $25.54 per share, resulting in proceeds of $714,609. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
152K
0%
3M change
32.77%
12M change
Total Value Held
$2.62 Million
Cheryl R Blanchard Transaction History
Also insider at
CRB
Cheryl R Blanchard
President, CEO, Director
Bedford, MA